We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Listing of countries with a known occurrence of high consequence infectious disease (HCID).
How to use a cost consequence analysis to evaluate your digital health product.
Guidance and information about high consequence infectious diseases and their management in England.
There are potential consequences for you, the director, if your company suffers insolvency.
Principles for managing cases of suspected high consequence infectious diseases in adult social care in England.
Urgent public health message advising that clade I mpox no longer meets the criteria of a high consequence infectious disease (HCID).
Why it's important to evaluate digital health products that have been developed rapidly and how to choose evaluation methods in these circumstances.
Companies become insolvent for a variety of reasons. What happens next will depend on the individual circumstances involved.
Report on Public Health England's recommended consequence assessment methodology, to meet the REPPIR 2019 requirements.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).